| RS267607510 |
GFAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alexander disease, Alexander disease |
| RS267607511 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS267607512 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS267607514 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS267607515 |
GFAP
|
Health Risk |
Likely pathogenic |
Alexander disease, Alexander disease |
| RS267607518 |
GFAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alexander disease, Alexander disease |
| RS267607526 |
GFAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alexander disease, Alexander disease |
| RS267607534 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, NEFH-related disorder |
| RS267607538 |
NEFL
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 1F |
| RS267607539 |
LMNA
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant |
| RS267607540 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant |
| RS267607542 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607543 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial partial lipodystrophy, Dunnigan type |
| RS267607545 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Emery-Dreifuss muscular dystrophy 2 |
| RS267607546 |
LMNA
|
Health Risk |
Pathogenic |
LMNA-related disorder, LMNA-related disorder |
| RS267607547 |
LMNA
|
Health Risk |
Pathogenic |
Hutchinson-Gilford syndrome, Hutchinson-Gilford syndrome |
| RS267607548 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Primary dilated cardiomyopathy |
| RS267607550 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607552 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, 8 conditions |
| RS267607554 |
LMNA
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS267607555 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial partial lipodystrophy, Dunnigan type |
| RS267607557 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607559 |
LMNA
|
Health Risk |
Likely pathogenic |
Heart-hand syndrome, Slovenian type |
| RS267607560 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2 |
| RS267607561 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS267607564 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiomyopathy |
| RS267607567 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607569 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607570 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1A, Cardiovascular phenotype |
| RS267607571 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2 |
| RS267607572 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2 |
| RS267607573 |
LMNA
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease type 2 |
| RS267607574 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Cardiomyopathy |
| RS267607575 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607576 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Primary dilated cardiomyopathy |
| RS267607577 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Primary dilated cardiomyopathy |
| RS267607578 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Dilated cardiomyopathy 1A |
| RS267607581 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Dilated cardiomyopathy 1A |
| RS267607582 |
LMNA
|
Health Risk |
Likely pathogenic |
Heart-hand syndrome, Slovenian type |
| RS267607584 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607587 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607588 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Papillary renal cell carcinoma type 1 |
| RS267607589 |
LMNA
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS267607590 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2 |
| RS267607591 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Lipodystrophy, Charcot-Marie-Tooth disease type 2 |
| RS267607592 |
LMNA
|
Health Risk |
Pathogenic |
Neuromuscular disease, Charcot-Marie-Tooth disease type 2 |
| RS267607593 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS267607594 |
LMNA
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS267607597 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607598 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Emery-Dreifuss muscular dystrophy 2 |
| RS267607599 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607600 |
LMNA
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to LMNA mutation, Cardiovascular phenotype |
| RS267607603 |
LMNA
|
Health Risk |
Likely pathogenic |
Familial partial lipodystrophy, Dunnigan type |
| RS267607606 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, 11 conditions |
| RS267607608 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Congenital muscular dystrophy due to LMNA mutation |
| RS267607609 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, 7 conditions |
| RS267607613 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Congenital muscular dystrophy due to LMNA mutation |
| RS267607614 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607615 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607617 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Dilated cardiomyopathy 1A |
| RS267607618 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease type 2 |
| RS267607620 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607622 |
LMNA
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1A, Charcot-Marie-Tooth disease type 2 |
| RS267607623 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS267607627 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607629 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS267607631 |
LMNA
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS267607632 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Emery-Dreifuss muscular dystrophy 2 |
| RS267607634 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy, Charcot-Marie-Tooth disease type 2 |
| RS267607636 |
LMNA
|
Health Risk |
Likely pathogenic |
— |
| RS267607637 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607638 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607639 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607640 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2 |
| RS267607644 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy, Charcot-Marie-Tooth disease type 2 |
| RS267607645 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS267607646 |
LMNA
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease type 2 |
| RS267607649 |
LMNA
|
Health Risk |
Pathogenic |
— |
| RS267607661 |
KRT5
|
Health Risk |
Likely pathogenic |
— |
| RS267607681 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiomyopathy |
| RS267607689 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS267607690 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS267607691 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS267607693 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS267607694 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS267607696 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS267607699 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS267607702 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS267607706 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS267607709 |
MLH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome, Colorectal cancer |
| RS267607710 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS267607711 |
MLH1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS267607712 |
MLH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS267607713 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms |
| RS267607715 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS267607716 |
MLH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome, Colorectal cancer |
| RS267607717 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS267607718 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS267607719 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch syndrome, Gastric cancer |
| RS267607720 |
MLH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |